CSI Market
Sign In | Register

Syndax Pharmaceuticals Inc (SNDX) Annual Balance Sheets

Annual · GAAP · USD millions
Access SNDX quarterly Balance Sheets →
The balance sheet data below highlights changes in Syndax Pharmaceuticals Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent134.93
Short-term Investments, Total259.14
Deposits Assets, Current AS19.62
Cash & Short-term Investments412.00
Accounts receivable38.00
Other Receivables6.40
Inventories32.75
Other Current Assets23.75
Prepaid Expense And Other Assets Current13.50
Total Current Assets528.08
Equipment/Property/Plant Net0.18
Long-term investments0.00
Other Assets, Noncurrent1.44
Restricted Cash-
Operating Lease Right Of Use Asset1.34
Total Assets529.71
Liabilities
Accounts Payable, Current AC16.58
Accrued Liabilities And Other Liabilities103.06
Derivative Liability, Current DE0.00
Loans Payable to Bank, Current LO10.00
Other Liabilities, Current0.47
Total Current Liabilities120.12
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent344.96
Total Liabilities465.08
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,570.75
Retained Earnings / Accumulated Deficit-1,506.58
Other Equity0.45
Common Stockholder's Equity64.63
Total Stockholder's Equity64.63
Liabilities & Stockholder's Equity529.71
4 historic quarters locked

Sign in to unlock the full Syndax Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Syndax Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: sndx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-076536

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License